ATE335743T1 - Verfahren zur verminderung von restalkoholen im kristallinen valacyclovir-hydrochlorid - Google Patents
Verfahren zur verminderung von restalkoholen im kristallinen valacyclovir-hydrochloridInfo
- Publication number
- ATE335743T1 ATE335743T1 AT03809127T AT03809127T ATE335743T1 AT E335743 T1 ATE335743 T1 AT E335743T1 AT 03809127 T AT03809127 T AT 03809127T AT 03809127 T AT03809127 T AT 03809127T AT E335743 T1 ATE335743 T1 AT E335743T1
- Authority
- AT
- Austria
- Prior art keywords
- valacyclovir hydrochloride
- reducing residual
- crystalline valacyclovir
- residual carbons
- residual process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41927002P | 2002-10-16 | 2002-10-16 | |
US42732002P | 2002-11-18 | 2002-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE335743T1 true ATE335743T1 (de) | 2006-09-15 |
Family
ID=32110230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03809127T ATE335743T1 (de) | 2002-10-16 | 2003-10-16 | Verfahren zur verminderung von restalkoholen im kristallinen valacyclovir-hydrochlorid |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050070711A1 (de) |
EP (1) | EP1551838B1 (de) |
AT (1) | ATE335743T1 (de) |
AU (1) | AU2003277433A1 (de) |
CA (1) | CA2501557A1 (de) |
DE (1) | DE60307494D1 (de) |
ES (1) | ES2270172T3 (de) |
WO (1) | WO2004035583A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2465420A1 (en) * | 2001-11-05 | 2003-05-15 | Glaxo Group Limited | Anhydrous crystal form of valaciclovir hydrochloride |
CA2649826A1 (en) * | 2001-11-14 | 2003-05-22 | Teva Pharmaceutical Industries Ltd. | Synthesis and purification of valacyclovir |
US20050059684A1 (en) * | 2002-10-16 | 2005-03-17 | Ben-Zion Dolitzky | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
US7786302B2 (en) * | 2003-05-30 | 2010-08-31 | Eczacibasi-Zentiva Kimyasal Urunler Sanayi Ve Ticaret A.S. | Crystalline forms of valacyclovir hydrochloride |
EP2014660A3 (de) * | 2003-06-02 | 2009-07-15 | Teva Pharmaceutical Industries Ltd | Neuartige kristalline Formen von Valacyclovir-Hydrochlorid |
JP2008504255A (ja) * | 2004-06-30 | 2008-02-14 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶塩酸バラシクロビル中の残留アルコールを低減する方法 |
EP1692134A2 (de) * | 2004-09-04 | 2006-08-23 | Teva Pharmaceutical Industries, Inc. | Valacyclovir-verunreinigung, herstellungsverfahren dafür und verwendung als referenzstandard |
EP1746098A1 (de) * | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir Polymorphe und Verfahren zu deren Herstellung |
AU2020334060A1 (en) * | 2019-08-19 | 2022-03-24 | Ucb Biosciences, Inc. | Polymorphic forms of deoxycytidine, compositions comprising the same and uses |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR5161M (de) * | 1965-03-25 | 1967-06-12 | ||
US3989849A (en) * | 1973-03-23 | 1976-11-02 | General Foods Corporation | Improving the flavor of decaffeinated coffee by radio frequency heating to rapidly dry coffee beans |
GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
US5270267A (en) * | 1989-05-31 | 1993-12-14 | Mitel Corporation | Curing and passivation of spin on glasses by a plasma process wherein an external polarization field is applied to the substrate |
EP0665229B1 (de) * | 1994-02-01 | 1999-11-17 | Ajinomoto Co., Inc. | Verfahren zur Herstellung von Nukleinsäurebasenderivaten |
JP2723088B2 (ja) * | 1994-09-07 | 1998-03-09 | 藤沢薬品工業株式会社 | セファロスポリン化合物の新規な結晶 |
GB9501178D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Guanine derivative |
GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
GB9717629D0 (en) * | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
US6258371B1 (en) * | 1998-04-03 | 2001-07-10 | Medtronic Inc | Method for making biocompatible medical article |
IL160721A0 (en) * | 2001-09-07 | 2004-08-31 | Teva Pharma | Crystalline forms of valacyclovir hydrochloride |
CA2649826A1 (en) * | 2001-11-14 | 2003-05-22 | Teva Pharmaceutical Industries Ltd. | Synthesis and purification of valacyclovir |
US20050059684A1 (en) * | 2002-10-16 | 2005-03-17 | Ben-Zion Dolitzky | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
US7199144B2 (en) * | 2003-04-21 | 2007-04-03 | Teva Pharmaceuticals Industries, Ltd. | Process for the preparation of valsartan and intermediates thereof |
-
2003
- 2003-10-16 AU AU2003277433A patent/AU2003277433A1/en not_active Abandoned
- 2003-10-16 DE DE60307494T patent/DE60307494D1/de not_active Expired - Lifetime
- 2003-10-16 AT AT03809127T patent/ATE335743T1/de not_active IP Right Cessation
- 2003-10-16 WO PCT/US2003/032995 patent/WO2004035583A1/en not_active Application Discontinuation
- 2003-10-16 US US10/688,538 patent/US20050070711A1/en not_active Abandoned
- 2003-10-16 EP EP03809127A patent/EP1551838B1/de not_active Expired - Lifetime
- 2003-10-16 ES ES03809127T patent/ES2270172T3/es not_active Expired - Lifetime
- 2003-10-16 CA CA002501557A patent/CA2501557A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003277433A1 (en) | 2004-05-04 |
CA2501557A1 (en) | 2004-04-29 |
WO2004035583A1 (en) | 2004-04-29 |
EP1551838A1 (de) | 2005-07-13 |
EP1551838B1 (de) | 2006-08-09 |
US20050070711A1 (en) | 2005-03-31 |
DE60307494D1 (de) | 2006-09-21 |
ES2270172T3 (es) | 2007-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE550319T1 (de) | Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats | |
ATE366725T1 (de) | Verfahren zur herstellung von gereinigten 1,3- substituierten imidazoliumsalzen | |
BR0015808A (pt) | Método e dispositivo para a purificação de uma solução aquosa de um ácido org nico tendo um ponto de ebulição na pressão atmosférica menor do que 450 c, mesmo, e, uso do método | |
ATE335743T1 (de) | Verfahren zur verminderung von restalkoholen im kristallinen valacyclovir-hydrochlorid | |
ATE453645T1 (de) | Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen | |
TW200504063A (en) | DPP-IV inhibitors | |
BRPI0212341B8 (pt) | compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos | |
BR0113940B1 (pt) | processo para preparar derivados de 4 - tioalquilbromobenzeno. | |
ATE521587T1 (de) | Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid | |
DE60104825D1 (de) | Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen | |
DE602005025002D1 (de) | Verfahren zur herstellung von brenztraubensäure | |
DE602005026827D1 (de) | Verfahren zur herstellung von isoindolderivaten | |
WO2006133257A3 (en) | Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy | |
ATE542591T1 (de) | Verfahren zur beseitigung von in organischen abwässern oder abgasen enthaltenen sauerstoffhaltigen organischen molekülen unter verwendung von aluminiumoxidagglomeraten | |
DE60124289D1 (de) | Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op) | |
ATE500214T1 (de) | Verfahren zur herstellung eines ethylamins | |
ATE542810T1 (de) | Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton | |
EE200300206A (et) | Kristalse N-formimidoüültienamütsiinmonohüdraadi (imipeneemmonohüdraadi) valmistamise meetod | |
ATE447563T1 (de) | Verfahren zur herstellung eines immunosuppresivums | |
ATE439348T1 (de) | Verfahren zum herstellen von carboxamiden | |
ATE370950T1 (de) | Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol | |
ATE389644T1 (de) | Verfahren zur destillativen aufarbeitung von tetrahydrofuran | |
ATE250026T1 (de) | Verfahren zur herstellung von n-(4,5-bis- methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid | |
ATE403418T1 (de) | Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid | |
DE60329668D1 (de) | Verfahren zur unterdrückung der ptx3 genexpression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |